nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCB1—lung cancer	0.185	1	CbGaD
Spironolactone—ABCC2—Paclitaxel—lung cancer	0.0406	0.0763	CbGbCtD
Spironolactone—ABCC2—Irinotecan—lung cancer	0.04	0.0753	CbGbCtD
Spironolactone—ABCC2—Vinblastine—lung cancer	0.0356	0.0669	CbGbCtD
Spironolactone—ABCC2—Cisplatin—lung cancer	0.0326	0.0614	CbGbCtD
Spironolactone—ABCC2—Etoposide—lung cancer	0.0321	0.0603	CbGbCtD
Spironolactone—ABCC2—Docetaxel—lung cancer	0.0293	0.0552	CbGbCtD
Spironolactone—ABCB1—Topotecan—lung cancer	0.0267	0.0502	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—lung cancer	0.0255	0.0481	CbGbCtD
Spironolactone—ABCB1—Gefitinib—lung cancer	0.0244	0.046	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—lung cancer	0.0219	0.0411	CbGbCtD
Spironolactone—CYP2C8—Erlotinib—lung cancer	0.0213	0.0401	CbGbCtD
Spironolactone—ABCC2—Methotrexate—lung cancer	0.0212	0.0398	CbGbCtD
Spironolactone—CYP2C8—Paclitaxel—lung cancer	0.0195	0.0367	CbGbCtD
Spironolactone—ABCB1—Vinorelbine—lung cancer	0.0188	0.0354	CbGbCtD
Spironolactone—CYP2C8—Etoposide—lung cancer	0.0154	0.029	CbGbCtD
Spironolactone—ABCB1—Crizotinib—lung cancer	0.015	0.0282	CbGbCtD
Spironolactone—ABCB1—Gemcitabine—lung cancer	0.0146	0.0275	CbGbCtD
Spironolactone—ABCB1—Erlotinib—lung cancer	0.0144	0.0272	CbGbCtD
Spironolactone—ABCB1—Paclitaxel—lung cancer	0.0132	0.0249	CbGbCtD
Spironolactone—ABCB1—Irinotecan—lung cancer	0.013	0.0245	CbGbCtD
Spironolactone—ABCB1—Vinblastine—lung cancer	0.0116	0.0218	CbGbCtD
Spironolactone—ABCB1—Cisplatin—lung cancer	0.0106	0.02	CbGbCtD
Spironolactone—ABCB1—Etoposide—lung cancer	0.0104	0.0197	CbGbCtD
Spironolactone—ABCB1—Docetaxel—lung cancer	0.00956	0.018	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—lung cancer	0.00713	0.0134	CbGbCtD
Spironolactone—ABCB1—Methotrexate—lung cancer	0.0069	0.013	CbGbCtD
Spironolactone—PGR—mammary gland—lung cancer	0.000998	0.0835	CbGeAlD
Spironolactone—Hydrocortisone—ANXA1—lung cancer	0.000839	0.247	CrCbGaD
Spironolactone—Testosterone Propionate—UGT1A1—lung cancer	0.000727	0.214	CrCbGaD
Spironolactone—PGR—respiratory system—lung cancer	0.000665	0.0556	CbGeAlD
Spironolactone—CYP2C8—mammary gland—lung cancer	0.000643	0.0538	CbGeAlD
Spironolactone—NR3C2—bronchus—lung cancer	0.000589	0.0493	CbGeAlD
Spironolactone—CYP11B2—lymph node—lung cancer	0.000589	0.0492	CbGeAlD
Spironolactone—PGR—epithelium—lung cancer	0.000556	0.0465	CbGeAlD
Spironolactone—NR3C2—trachea—lung cancer	0.000529	0.0442	CbGeAlD
Spironolactone—NR3C2—cardiac atrium—lung cancer	0.000497	0.0415	CbGeAlD
Spironolactone—AR—epithelium—lung cancer	0.000443	0.037	CbGeAlD
Spironolactone—AR—bronchus—lung cancer	0.000436	0.0365	CbGeAlD
Spironolactone—SHBG—bone marrow—lung cancer	0.000433	0.0362	CbGeAlD
Spironolactone—NR3C1—respiratory system—lung cancer	0.000384	0.0321	CbGeAlD
Spironolactone—NR3C2—lung—lung cancer	0.00038	0.0318	CbGeAlD
Spironolactone—AR—cardiac atrium—lung cancer	0.000368	0.0308	CbGeAlD
Spironolactone—PGR—lung—lung cancer	0.000353	0.0295	CbGeAlD
Spironolactone—Renal failure—Paclitaxel—lung cancer	0.000346	0.00256	CcSEcCtD
Spironolactone—Discomfort—Vinorelbine—lung cancer	0.000344	0.00254	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—lung cancer	0.000344	0.00254	CcSEcCtD
Spironolactone—Alopecia—Irinotecan—lung cancer	0.000342	0.00253	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Topotecan—lung cancer	0.000337	0.00249	CcSEcCtD
Spironolactone—Agranulocytosis—Etoposide—lung cancer	0.000335	0.00248	CcSEcCtD
Spironolactone—Vomiting—Teniposide—lung cancer	0.000334	0.00247	CcSEcCtD
Spironolactone—Anaphylactic shock—Vinorelbine—lung cancer	0.000334	0.00247	CcSEcCtD
Spironolactone—Alopecia—Gemcitabine—lung cancer	0.000333	0.00247	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Erlotinib—lung cancer	0.000333	0.00246	CcSEcCtD
Spironolactone—Rash—Teniposide—lung cancer	0.000332	0.00245	CcSEcCtD
Spironolactone—Dermatitis—Teniposide—lung cancer	0.000331	0.00245	CcSEcCtD
Spironolactone—Feeling abnormal—Vinblastine—lung cancer	0.000331	0.00245	CcSEcCtD
Spironolactone—Headache—Teniposide—lung cancer	0.00033	0.00244	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—lung cancer	0.000327	0.00242	CcSEcCtD
Spironolactone—Thrombocytopenia—Vinorelbine—lung cancer	0.000327	0.00242	CcSEcCtD
Spironolactone—SLCO1A2—lung—lung cancer	0.000326	0.0272	CbGeAlD
Spironolactone—Muscle spasms—Irinotecan—lung cancer	0.000324	0.0024	CcSEcCtD
Spironolactone—Feeling abnormal—Topotecan—lung cancer	0.000321	0.00238	CcSEcCtD
Spironolactone—NR3C1—epithelium—lung cancer	0.000321	0.0268	CbGeAlD
Spironolactone—NR3C1—bronchus—lung cancer	0.000316	0.0264	CbGeAlD
Spironolactone—Ill-defined disorder—Irinotecan—lung cancer	0.000313	0.00231	CcSEcCtD
Spironolactone—Nausea—Teniposide—lung cancer	0.000312	0.00231	CcSEcCtD
Spironolactone—Alopecia—Cisplatin—lung cancer	0.000311	0.0023	CcSEcCtD
Spironolactone—Urticaria—Topotecan—lung cancer	0.00031	0.00229	CcSEcCtD
Spironolactone—Body temperature increased—Topotecan—lung cancer	0.000308	0.00228	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—lung cancer	0.000306	0.00226	CcSEcCtD
Spironolactone—Body temperature increased—Erlotinib—lung cancer	0.000305	0.00226	CcSEcCtD
Spironolactone—Ill-defined disorder—Gemcitabine—lung cancer	0.000305	0.00225	CcSEcCtD
Spironolactone—Erythema multiforme—Etoposide—lung cancer	0.000305	0.00225	CcSEcCtD
Spironolactone—Malaise—Irinotecan—lung cancer	0.000304	0.00225	CcSEcCtD
Spironolactone—Renal failure acute—Methotrexate—lung cancer	0.000302	0.00223	CcSEcCtD
Spironolactone—Leukopenia—Irinotecan—lung cancer	0.000302	0.00223	CcSEcCtD
Spironolactone—Erythema multiforme—Paclitaxel—lung cancer	0.000299	0.00221	CcSEcCtD
Spironolactone—Malaise—Gemcitabine—lung cancer	0.000296	0.00219	CcSEcCtD
Spironolactone—Hypersensitivity—Vinblastine—lung cancer	0.000296	0.00219	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000296	0.00219	CcSEcCtD
Spironolactone—Muscle spasms—Cisplatin—lung cancer	0.000294	0.00218	CcSEcCtD
Spironolactone—Leukopenia—Gemcitabine—lung cancer	0.000294	0.00217	CcSEcCtD
Spironolactone—Renal failure—Docetaxel—lung cancer	0.000293	0.00217	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000288	0.00213	CcSEcCtD
Spironolactone—Hypersensitivity—Topotecan—lung cancer	0.000287	0.00213	CcSEcCtD
Spironolactone—Alopecia—Etoposide—lung cancer	0.000285	0.00211	CcSEcCtD
Spironolactone—Lethargy—Methotrexate—lung cancer	0.000285	0.00211	CcSEcCtD
Spironolactone—Ill-defined disorder—Cisplatin—lung cancer	0.000284	0.0021	CcSEcCtD
Spironolactone—NR3C1—trachea—lung cancer	0.000284	0.0237	CbGeAlD
Spironolactone—Discomfort—Irinotecan—lung cancer	0.000284	0.0021	CcSEcCtD
Spironolactone—AR—lung—lung cancer	0.000281	0.0235	CbGeAlD
Spironolactone—Alopecia—Paclitaxel—lung cancer	0.000279	0.00206	CcSEcCtD
Spironolactone—Agranulocytosis—Docetaxel—lung cancer	0.000278	0.00206	CcSEcCtD
Spironolactone—Confusional state—Irinotecan—lung cancer	0.000277	0.00205	CcSEcCtD
Spironolactone—Discomfort—Gemcitabine—lung cancer	0.000276	0.00204	CcSEcCtD
Spironolactone—Malaise—Cisplatin—lung cancer	0.000276	0.00204	CcSEcCtD
Spironolactone—Pruritus—Topotecan—lung cancer	0.000276	0.00204	CcSEcCtD
Spironolactone—Anaphylactic shock—Irinotecan—lung cancer	0.000275	0.00203	CcSEcCtD
Spironolactone—Feeling abnormal—Vinorelbine—lung cancer	0.000275	0.00203	CcSEcCtD
Spironolactone—Diarrhoea—Vinblastine—lung cancer	0.000275	0.00203	CcSEcCtD
Spironolactone—Leukopenia—Cisplatin—lung cancer	0.000274	0.00203	CcSEcCtD
Spironolactone—Pruritus—Erlotinib—lung cancer	0.000273	0.00202	CcSEcCtD
Spironolactone—Muscle spasms—Etoposide—lung cancer	0.00027	0.00199	CcSEcCtD
Spironolactone—Thrombocytopenia—Irinotecan—lung cancer	0.000269	0.00199	CcSEcCtD
Spironolactone—Anaphylactic shock—Gemcitabine—lung cancer	0.000268	0.00198	CcSEcCtD
Spironolactone—Diarrhoea—Topotecan—lung cancer	0.000267	0.00197	CcSEcCtD
Spironolactone—NR3C1—cardiac atrium—lung cancer	0.000266	0.0223	CbGeAlD
Spironolactone—Dizziness—Vinblastine—lung cancer	0.000265	0.00196	CcSEcCtD
Spironolactone—Urticaria—Vinorelbine—lung cancer	0.000265	0.00196	CcSEcCtD
Spironolactone—Muscle spasms—Paclitaxel—lung cancer	0.000264	0.00196	CcSEcCtD
Spironolactone—Diarrhoea—Erlotinib—lung cancer	0.000264	0.00195	CcSEcCtD
Spironolactone—Body temperature increased—Vinorelbine—lung cancer	0.000264	0.00195	CcSEcCtD
Spironolactone—Thrombocytopenia—Gemcitabine—lung cancer	0.000262	0.00194	CcSEcCtD
Spironolactone—Ataxia—Methotrexate—lung cancer	0.000262	0.00194	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—lung cancer	0.000262	0.00193	CcSEcCtD
Spironolactone—Ill-defined disorder—Etoposide—lung cancer	0.00026	0.00192	CcSEcCtD
Spironolactone—NR3C2—lymph node—lung cancer	0.00026	0.0217	CbGeAlD
Spironolactone—Dizziness—Topotecan—lung cancer	0.000258	0.00191	CcSEcCtD
Spironolactone—Discomfort—Cisplatin—lung cancer	0.000257	0.0019	CcSEcCtD
Spironolactone—Vomiting—Vinblastine—lung cancer	0.000255	0.00189	CcSEcCtD
Spironolactone—Dizziness—Erlotinib—lung cancer	0.000255	0.00189	CcSEcCtD
Spironolactone—Ill-defined disorder—Paclitaxel—lung cancer	0.000255	0.00189	CcSEcCtD
Spironolactone—Erythema multiforme—Docetaxel—lung cancer	0.000253	0.00187	CcSEcCtD
Spironolactone—Malaise—Etoposide—lung cancer	0.000253	0.00187	CcSEcCtD
Spironolactone—Headache—Vinblastine—lung cancer	0.000251	0.00186	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000251	0.00186	CcSEcCtD
Spironolactone—Leukopenia—Etoposide—lung cancer	0.000251	0.00186	CcSEcCtD
Spironolactone—Anaphylactic shock—Cisplatin—lung cancer	0.00025	0.00185	CcSEcCtD
Spironolactone—Vomiting—Topotecan—lung cancer	0.000248	0.00183	CcSEcCtD
Spironolactone—Malaise—Paclitaxel—lung cancer	0.000248	0.00183	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—lung cancer	0.000246	0.00182	CcSEcCtD
Spironolactone—Leukopenia—Paclitaxel—lung cancer	0.000246	0.00182	CcSEcCtD
Spironolactone—Rash—Topotecan—lung cancer	0.000246	0.00182	CcSEcCtD
Spironolactone—Hypersensitivity—Vinorelbine—lung cancer	0.000246	0.00182	CcSEcCtD
Spironolactone—Dermatitis—Topotecan—lung cancer	0.000246	0.00182	CcSEcCtD
Spironolactone—Vomiting—Erlotinib—lung cancer	0.000245	0.00181	CcSEcCtD
Spironolactone—Somnolence—Irinotecan—lung cancer	0.000245	0.00181	CcSEcCtD
Spironolactone—Thrombocytopenia—Cisplatin—lung cancer	0.000245	0.00181	CcSEcCtD
Spironolactone—Headache—Topotecan—lung cancer	0.000244	0.00181	CcSEcCtD
Spironolactone—Rash—Erlotinib—lung cancer	0.000243	0.0018	CcSEcCtD
Spironolactone—Dermatitis—Erlotinib—lung cancer	0.000243	0.0018	CcSEcCtD
Spironolactone—Headache—Erlotinib—lung cancer	0.000242	0.00179	CcSEcCtD
Spironolactone—PGR—lymph node—lung cancer	0.000242	0.0202	CbGeAlD
Spironolactone—Eosinophilia—Methotrexate—lung cancer	0.000239	0.00177	CcSEcCtD
Spironolactone—Drospirenone—PTGS2—lung cancer	0.000238	0.0701	CrCbGaD
Spironolactone—Nausea—Vinblastine—lung cancer	0.000238	0.00176	CcSEcCtD
Spironolactone—Somnolence—Gemcitabine—lung cancer	0.000238	0.00176	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000237	0.00176	CcSEcCtD
Spironolactone—Alopecia—Docetaxel—lung cancer	0.000237	0.00175	CcSEcCtD
Spironolactone—Pruritus—Vinorelbine—lung cancer	0.000236	0.00175	CcSEcCtD
Spironolactone—Discomfort—Etoposide—lung cancer	0.000236	0.00174	CcSEcCtD
Spironolactone—Megestrol acetate—ABCB1—lung cancer	0.000232	0.0683	CrCbGaD
Spironolactone—Nausea—Topotecan—lung cancer	0.000232	0.00171	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000231	0.00171	CcSEcCtD
Spironolactone—Discomfort—Paclitaxel—lung cancer	0.000231	0.00171	CcSEcCtD
Spironolactone—Confusional state—Etoposide—lung cancer	0.000231	0.00171	CcSEcCtD
Spironolactone—Hydrocortisone—ABCG2—lung cancer	0.00023	0.0678	CrCbGaD
Spironolactone—Nausea—Erlotinib—lung cancer	0.000229	0.0017	CcSEcCtD
Spironolactone—Anaphylactic shock—Etoposide—lung cancer	0.000229	0.00169	CcSEcCtD
Spironolactone—Diarrhoea—Vinorelbine—lung cancer	0.000228	0.00169	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—lung cancer	0.000227	0.00168	CcSEcCtD
Spironolactone—Feeling abnormal—Irinotecan—lung cancer	0.000227	0.00168	CcSEcCtD
Spironolactone—Confusional state—Paclitaxel—lung cancer	0.000226	0.00167	CcSEcCtD
Spironolactone—NR3C1—bone marrow—lung cancer	0.000225	0.0188	CbGeAlD
Spironolactone—Anaphylactic shock—Paclitaxel—lung cancer	0.000224	0.00166	CcSEcCtD
Spironolactone—Thrombocytopenia—Etoposide—lung cancer	0.000224	0.00166	CcSEcCtD
Spironolactone—Muscle spasms—Docetaxel—lung cancer	0.000224	0.00166	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—lung cancer	0.000222	0.00164	CcSEcCtD
Spironolactone—Feeling abnormal—Gemcitabine—lung cancer	0.000221	0.00163	CcSEcCtD
Spironolactone—Dizziness—Vinorelbine—lung cancer	0.000221	0.00163	CcSEcCtD
Spironolactone—Thrombocytopenia—Paclitaxel—lung cancer	0.00022	0.00162	CcSEcCtD
Spironolactone—Body temperature increased—Irinotecan—lung cancer	0.000217	0.00161	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000217	0.00161	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000216	0.0016	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—lung cancer	0.000215	0.00159	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—lung cancer	0.000214	0.00158	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000213	0.00158	CcSEcCtD
Spironolactone—Vomiting—Vinorelbine—lung cancer	0.000212	0.00157	CcSEcCtD
Spironolactone—Body temperature increased—Gemcitabine—lung cancer	0.000212	0.00157	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—lung cancer	0.000211	0.00156	CcSEcCtD
Spironolactone—Rash—Vinorelbine—lung cancer	0.00021	0.00156	CcSEcCtD
Spironolactone—Dermatitis—Vinorelbine—lung cancer	0.00021	0.00155	CcSEcCtD
Spironolactone—Progesterone—CYP2A6—lung cancer	0.00021	0.0617	CrCbGaD
Spironolactone—Headache—Vinorelbine—lung cancer	0.000209	0.00155	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—lung cancer	0.000209	0.00154	CcSEcCtD
Spironolactone—ABCC2—lymph node—lung cancer	0.000207	0.0174	CbGeAlD
Spironolactone—Eosinophilia—Doxorubicin—lung cancer	0.000207	0.00153	CcSEcCtD
Spironolactone—Feeling abnormal—Cisplatin—lung cancer	0.000206	0.00152	CcSEcCtD
Spironolactone—ABCB1—respiratory system—lung cancer	0.000205	0.0172	CbGeAlD
Spironolactone—NR3C1—lung—lung cancer	0.000204	0.017	CbGeAlD
Spironolactone—Somnolence—Etoposide—lung cancer	0.000203	0.0015	CcSEcCtD
Spironolactone—Hypersensitivity—Irinotecan—lung cancer	0.000203	0.0015	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—lung cancer	0.000201	0.00148	CcSEcCtD
Spironolactone—Somnolence—Paclitaxel—lung cancer	0.000199	0.00148	CcSEcCtD
Spironolactone—Nausea—Vinorelbine—lung cancer	0.000198	0.00147	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—lung cancer	0.000198	0.00146	CcSEcCtD
Spironolactone—Body temperature increased—Cisplatin—lung cancer	0.000197	0.00146	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000194	0.00143	CcSEcCtD
Spironolactone—AR—lymph node—lung cancer	0.000192	0.0161	CbGeAlD
Spironolactone—Confusional state—Docetaxel—lung cancer	0.000192	0.00142	CcSEcCtD
Spironolactone—Anaphylactic shock—Docetaxel—lung cancer	0.00019	0.00141	CcSEcCtD
Spironolactone—Pruritus—Gemcitabine—lung cancer	0.00019	0.0014	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—lung cancer	0.000189	0.00139	CcSEcCtD
Spironolactone—Diarrhoea—Irinotecan—lung cancer	0.000188	0.00139	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—lung cancer	0.000186	0.00138	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—lung cancer	0.000186	0.00138	CcSEcCtD
Spironolactone—Feeling abnormal—Paclitaxel—lung cancer	0.000185	0.00137	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000184	0.00136	CcSEcCtD
Spironolactone—Hypersensitivity—Cisplatin—lung cancer	0.000184	0.00136	CcSEcCtD
Spironolactone—Diarrhoea—Gemcitabine—lung cancer	0.000183	0.00136	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—lung cancer	0.000183	0.00135	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—lung cancer	0.000182	0.00135	CcSEcCtD
Spironolactone—Dizziness—Irinotecan—lung cancer	0.000182	0.00135	CcSEcCtD
Spironolactone—Urticaria—Etoposide—lung cancer	0.000182	0.00134	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—lung cancer	0.000181	0.00134	CcSEcCtD
Spironolactone—Urticaria—Paclitaxel—lung cancer	0.000178	0.00132	CcSEcCtD
Spironolactone—Testosterone—ABCG2—lung cancer	0.000177	0.0522	CrCbGaD
Spironolactone—Body temperature increased—Paclitaxel—lung cancer	0.000177	0.00131	CcSEcCtD
Spironolactone—Vomiting—Irinotecan—lung cancer	0.000175	0.00129	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—lung cancer	0.000174	0.00128	CcSEcCtD
Spironolactone—Rash—Irinotecan—lung cancer	0.000173	0.00128	CcSEcCtD
Spironolactone—Dermatitis—Irinotecan—lung cancer	0.000173	0.00128	CcSEcCtD
Spironolactone—Headache—Irinotecan—lung cancer	0.000172	0.00127	CcSEcCtD
Spironolactone—ABCB1—epithelium—lung cancer	0.000172	0.0144	CbGeAlD
Spironolactone—Diarrhoea—Cisplatin—lung cancer	0.000171	0.00126	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—lung cancer	0.00017	0.00126	CcSEcCtD
Spironolactone—Vomiting—Gemcitabine—lung cancer	0.00017	0.00126	CcSEcCtD
Spironolactone—Somnolence—Docetaxel—lung cancer	0.000169	0.00125	CcSEcCtD
Spironolactone—Rash—Gemcitabine—lung cancer	0.000169	0.00125	CcSEcCtD
Spironolactone—Dermatitis—Gemcitabine—lung cancer	0.000169	0.00125	CcSEcCtD
Spironolactone—Hypersensitivity—Etoposide—lung cancer	0.000169	0.00125	CcSEcCtD
Spironolactone—Headache—Gemcitabine—lung cancer	0.000168	0.00124	CcSEcCtD
Spironolactone—Hypersensitivity—Paclitaxel—lung cancer	0.000165	0.00122	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000164	0.00121	CcSEcCtD
Spironolactone—Nausea—Irinotecan—lung cancer	0.000163	0.00121	CcSEcCtD
Spironolactone—Pruritus—Etoposide—lung cancer	0.000162	0.0012	CcSEcCtD
Spironolactone—Nausea—Gemcitabine—lung cancer	0.000159	0.00118	CcSEcCtD
Spironolactone—Vomiting—Cisplatin—lung cancer	0.000159	0.00117	CcSEcCtD
Spironolactone—Pruritus—Paclitaxel—lung cancer	0.000159	0.00117	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—lung cancer	0.000158	0.00117	CcSEcCtD
Spironolactone—Rash—Cisplatin—lung cancer	0.000157	0.00116	CcSEcCtD
Spironolactone—Dermatitis—Cisplatin—lung cancer	0.000157	0.00116	CcSEcCtD
Spironolactone—Feeling abnormal—Docetaxel—lung cancer	0.000157	0.00116	CcSEcCtD
Spironolactone—Diarrhoea—Etoposide—lung cancer	0.000157	0.00116	CcSEcCtD
Spironolactone—Ill-defined disorder—Methotrexate—lung cancer	0.000156	0.00115	CcSEcCtD
Spironolactone—Diarrhoea—Paclitaxel—lung cancer	0.000154	0.00114	CcSEcCtD
Spironolactone—ABCB1—trachea—lung cancer	0.000152	0.0127	CbGeAlD
Spironolactone—Malaise—Methotrexate—lung cancer	0.000151	0.00112	CcSEcCtD
Spironolactone—Dizziness—Etoposide—lung cancer	0.000151	0.00112	CcSEcCtD
Spironolactone—Body temperature increased—Docetaxel—lung cancer	0.00015	0.00111	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—lung cancer	0.00015	0.00111	CcSEcCtD
Spironolactone—Dizziness—Paclitaxel—lung cancer	0.000148	0.0011	CcSEcCtD
Spironolactone—Nausea—Cisplatin—lung cancer	0.000148	0.0011	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—lung cancer	0.000148	0.00109	CcSEcCtD
Spironolactone—Progesterone—CYP1A1—lung cancer	0.000147	0.0432	CrCbGaD
Spironolactone—Vomiting—Etoposide—lung cancer	0.000145	0.00108	CcSEcCtD
Spironolactone—Rash—Etoposide—lung cancer	0.000144	0.00107	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—lung cancer	0.000144	0.00107	CcSEcCtD
Spironolactone—Headache—Etoposide—lung cancer	0.000143	0.00106	CcSEcCtD
Spironolactone—Vomiting—Paclitaxel—lung cancer	0.000143	0.00106	CcSEcCtD
Spironolactone—Rash—Paclitaxel—lung cancer	0.000141	0.00105	CcSEcCtD
Spironolactone—Dermatitis—Paclitaxel—lung cancer	0.000141	0.00105	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—lung cancer	0.000141	0.00104	CcSEcCtD
Spironolactone—Headache—Paclitaxel—lung cancer	0.000141	0.00104	CcSEcCtD
Spironolactone—Hypersensitivity—Docetaxel—lung cancer	0.00014	0.00104	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—lung cancer	0.00014	0.00103	CcSEcCtD
Spironolactone—NR3C1—lymph node—lung cancer	0.000139	0.0117	CbGeAlD
Spironolactone—Testosterone—CYP1A1—lung cancer	0.000139	0.0409	CrCbGaD
Spironolactone—Confusional state—Methotrexate—lung cancer	0.000138	0.00102	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—lung cancer	0.000137	0.00101	CcSEcCtD
Spironolactone—Nausea—Etoposide—lung cancer	0.000136	0.00101	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—lung cancer	0.000135	0.000998	CcSEcCtD
Spironolactone—Pruritus—Docetaxel—lung cancer	0.000135	0.000995	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—lung cancer	0.000134	0.000993	CcSEcCtD
Spironolactone—Methyltestosterone—ALB—lung cancer	0.000133	0.0392	CrCbGaD
Spironolactone—Nausea—Paclitaxel—lung cancer	0.000133	0.000986	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—lung cancer	0.000131	0.00097	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—lung cancer	0.00013	0.000963	CcSEcCtD
Spironolactone—Diarrhoea—Docetaxel—lung cancer	0.00013	0.000962	CcSEcCtD
Spironolactone—Dizziness—Docetaxel—lung cancer	0.000126	0.00093	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—lung cancer	0.000122	0.000905	CcSEcCtD
Spironolactone—Somnolence—Methotrexate—lung cancer	0.000122	0.000901	CcSEcCtD
Spironolactone—Vomiting—Docetaxel—lung cancer	0.000121	0.000894	CcSEcCtD
Spironolactone—ABCB1—bone marrow—lung cancer	0.00012	0.0101	CbGeAlD
Spironolactone—Rash—Docetaxel—lung cancer	0.00012	0.000887	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—lung cancer	0.00012	0.000886	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—lung cancer	0.00012	0.000885	CcSEcCtD
Spironolactone—Headache—Docetaxel—lung cancer	0.000119	0.000881	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—lung cancer	0.000119	0.000878	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000118	0.000875	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—lung cancer	0.000116	0.00086	CcSEcCtD
Spironolactone—Nausea—Docetaxel—lung cancer	0.000113	0.000836	CcSEcCtD
Spironolactone—Feeling abnormal—Methotrexate—lung cancer	0.000113	0.000836	CcSEcCtD
Spironolactone—ABCB1—lung—lung cancer	0.000109	0.00912	CbGeAlD
Spironolactone—Urticaria—Methotrexate—lung cancer	0.000109	0.000805	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—lung cancer	0.000108	0.000802	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—lung cancer	0.000106	0.00078	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000102	0.000758	CcSEcCtD
Spironolactone—Hypersensitivity—Methotrexate—lung cancer	0.000101	0.000747	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—lung cancer	9.78e-05	0.000723	CcSEcCtD
Spironolactone—Pruritus—Methotrexate—lung cancer	9.7e-05	0.000717	CcSEcCtD
Spironolactone—Hydrocortisone—ABCB1—lung cancer	9.59e-05	0.0282	CrCbGaD
Spironolactone—Urticaria—Doxorubicin—lung cancer	9.43e-05	0.000697	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—lung cancer	9.38e-05	0.000694	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—lung cancer	9.38e-05	0.000694	CcSEcCtD
Spironolactone—Dizziness—Methotrexate—lung cancer	9.06e-05	0.00067	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—lung cancer	8.74e-05	0.000647	CcSEcCtD
Spironolactone—Vomiting—Methotrexate—lung cancer	8.71e-05	0.000645	CcSEcCtD
Spironolactone—Rash—Methotrexate—lung cancer	8.64e-05	0.000639	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—lung cancer	8.63e-05	0.000639	CcSEcCtD
Spironolactone—Headache—Methotrexate—lung cancer	8.59e-05	0.000635	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—lung cancer	8.4e-05	0.000621	CcSEcCtD
Spironolactone—Nausea—Methotrexate—lung cancer	8.14e-05	0.000602	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—lung cancer	8.12e-05	0.000601	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—lung cancer	7.85e-05	0.000581	CcSEcCtD
Spironolactone—Progesterone—ABCB1—lung cancer	7.81e-05	0.023	CrCbGaD
Spironolactone—Testosterone—ALB—lung cancer	7.74e-05	0.0228	CrCbGaD
Spironolactone—Vomiting—Doxorubicin—lung cancer	7.55e-05	0.000558	CcSEcCtD
Spironolactone—Rash—Doxorubicin—lung cancer	7.48e-05	0.000554	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—lung cancer	7.48e-05	0.000553	CcSEcCtD
Spironolactone—ABCB1—lymph node—lung cancer	7.46e-05	0.00624	CbGeAlD
Spironolactone—Headache—Doxorubicin—lung cancer	7.43e-05	0.00055	CcSEcCtD
Spironolactone—Testosterone—ABCB1—lung cancer	7.39e-05	0.0217	CrCbGaD
Spironolactone—Nausea—Doxorubicin—lung cancer	7.05e-05	0.000521	CcSEcCtD
Spironolactone—ABCB1—Metabolism—CKB—lung cancer	1.86e-05	0.00014	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.86e-05	0.000139	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.85e-05	0.000139	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—JUNB—lung cancer	1.84e-05	0.000138	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.84e-05	0.000138	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP2E1—lung cancer	1.83e-05	0.000137	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2A7—lung cancer	1.82e-05	0.000136	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FOXO3—lung cancer	1.81e-05	0.000136	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—POMC—lung cancer	1.81e-05	0.000136	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NQO1—lung cancer	1.81e-05	0.000136	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.8e-05	0.000135	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOA1—lung cancer	1.8e-05	0.000135	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SDC4—lung cancer	1.78e-05	0.000133	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.77e-05	0.000133	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CREBBP—lung cancer	1.76e-05	0.000132	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ERCC2—lung cancer	1.76e-05	0.000132	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.75e-05	0.000131	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CNDP2—lung cancer	1.75e-05	0.000131	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM2—lung cancer	1.75e-05	0.000131	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ALB—lung cancer	1.73e-05	0.00013	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—RAF1—lung cancer	1.72e-05	0.000129	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.72e-05	0.000129	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTMR3—lung cancer	1.7e-05	0.000128	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AVP—lung cancer	1.7e-05	0.000127	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MAPK3—lung cancer	1.69e-05	0.000127	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CREBBP—lung cancer	1.69e-05	0.000127	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CD—lung cancer	1.67e-05	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.67e-05	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PGAM1—lung cancer	1.66e-05	0.000125	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALB—lung cancer	1.65e-05	0.000124	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—lung cancer	1.65e-05	0.000124	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CG—lung cancer	1.64e-05	0.000123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1R—lung cancer	1.63e-05	0.000123	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—STK11—lung cancer	1.63e-05	0.000122	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.62e-05	0.000122	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.62e-05	0.000122	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RRM1—lung cancer	1.62e-05	0.000122	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA3—lung cancer	1.62e-05	0.000122	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HES1—lung cancer	1.6e-05	0.00012	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—lung cancer	1.59e-05	0.000119	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2A7—lung cancer	1.58e-05	0.000119	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.57e-05	0.000118	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	1.57e-05	0.000118	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.57e-05	0.000118	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—POMC—lung cancer	1.56e-05	0.000117	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SDC4—lung cancer	1.55e-05	0.000116	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.53e-05	0.000115	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—B4GALT5—lung cancer	1.52e-05	0.000114	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CREBBP—lung cancer	1.52e-05	0.000114	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTP1—lung cancer	1.51e-05	0.000113	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.49e-05	0.000112	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA4—lung cancer	1.48e-05	0.000111	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB3—lung cancer	1.47e-05	0.00011	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAT—lung cancer	1.47e-05	0.00011	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CB—lung cancer	1.46e-05	0.000109	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.46e-05	0.000109	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.45e-05	0.000109	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.45e-05	0.000109	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—lung cancer	1.44e-05	0.000108	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA2—lung cancer	1.44e-05	0.000108	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—lung cancer	1.44e-05	0.000108	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—lung cancer	1.43e-05	0.000107	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—lung cancer	1.42e-05	0.000107	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.41e-05	0.000106	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA3—lung cancer	1.41e-05	0.000106	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RRM1—lung cancer	1.41e-05	0.000106	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—lung cancer	1.41e-05	0.000106	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—lung cancer	1.4e-05	0.000105	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA1—lung cancer	1.39e-05	0.000105	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—lung cancer	1.38e-05	0.000104	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCC3—lung cancer	1.38e-05	0.000103	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGFR1—lung cancer	1.37e-05	0.000102	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.35e-05	0.000101	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—lung cancer	1.34e-05	0.000101	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.34e-05	0.0001	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C1—lung cancer	1.33e-05	0.0001	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ERCC2—lung cancer	1.33e-05	0.0001	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—B4GALT5—lung cancer	1.33e-05	9.96e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A1—lung cancer	1.31e-05	9.85e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.3e-05	9.77e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ERCC2—lung cancer	1.3e-05	9.77e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOA1—lung cancer	1.3e-05	9.74e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—UGT1A1—lung cancer	1.29e-05	9.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA4—lung cancer	1.29e-05	9.68e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CREBBP—lung cancer	1.29e-05	9.66e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—lung cancer	1.29e-05	9.65e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.27e-05	9.56e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—lung cancer	1.26e-05	9.45e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA2—lung cancer	1.26e-05	9.44e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—lung cancer	1.26e-05	9.43e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNG11—lung cancer	1.25e-05	9.37e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—lung cancer	1.24e-05	9.34e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.24e-05	9.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA1—lung cancer	1.21e-05	9.11e-05	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	1.2e-05	9.03e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.2e-05	9.03e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—EP300—lung cancer	1.2e-05	9.01e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCC3—lung cancer	1.2e-05	9e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALDOA—lung cancer	1.19e-05	8.92e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—lung cancer	1.18e-05	8.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KIT—lung cancer	1.18e-05	8.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—lung cancer	1.18e-05	8.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGF—lung cancer	1.17e-05	8.79e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C1—lung cancer	1.16e-05	8.72e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA3—lung cancer	1.15e-05	8.66e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—lung cancer	1.14e-05	8.57e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.13e-05	8.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UGT1A1—lung cancer	1.13e-05	8.47e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—POMC—lung cancer	1.13e-05	8.46e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOA1—lung cancer	1.13e-05	8.45e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ADCY1—lung cancer	1.12e-05	8.42e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCG2—lung cancer	1.12e-05	8.42e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—lung cancer	1.11e-05	8.36e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.1e-05	8.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HPGDS—lung cancer	1.1e-05	8.26e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—lung cancer	1.1e-05	8.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6R—lung cancer	1.1e-05	8.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREBBP—lung cancer	1.1e-05	8.24e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.09e-05	8.21e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNG11—lung cancer	1.09e-05	8.16e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—lung cancer	1.09e-05	8.14e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.08e-05	8.1e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.08e-05	8.09e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.07e-05	8.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—lung cancer	1.07e-05	8.01e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GCLC—lung cancer	1.06e-05	7.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2A6—lung cancer	1.06e-05	7.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.05e-05	7.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAP2K1—lung cancer	1.05e-05	7.87e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—lung cancer	1.04e-05	7.82e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALDOA—lung cancer	1.04e-05	7.77e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—EP300—lung cancer	1.03e-05	7.77e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—lung cancer	1.03e-05	7.74e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.03e-05	7.72e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—lung cancer	1.03e-05	7.71e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA3—lung cancer	1.01e-05	7.55e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—lung cancer	1e-05	7.52e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO1—lung cancer	1e-05	7.51e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.97e-06	7.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.84e-06	7.39e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—POMC—lung cancer	9.78e-06	7.34e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADCY1—lung cancer	9.78e-06	7.34e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCG2—lung cancer	9.78e-06	7.34e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CREBBP—lung cancer	9.76e-06	7.33e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HPGDS—lung cancer	9.59e-06	7.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—lung cancer	9.59e-06	7.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPP2R1B—lung cancer	9.53e-06	7.15e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CREBBP—lung cancer	9.53e-06	7.15e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MDM2—lung cancer	9.33e-06	7e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—lung cancer	9.3e-06	6.98e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAF1—lung cancer	9.3e-06	6.98e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—lung cancer	9.2e-06	6.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GCLC—lung cancer	9.19e-06	6.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2A6—lung cancer	9.19e-06	6.9e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MTOR—lung cancer	9.08e-06	6.81e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—lung cancer	9.08e-06	6.81e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—lung cancer	9.03e-06	6.78e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	9.03e-06	6.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2E1—lung cancer	8.97e-06	6.74e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—lung cancer	8.92e-06	6.69e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—lung cancer	8.88e-06	6.67e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NQO1—lung cancer	8.87e-06	6.66e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—lung cancer	8.72e-06	6.55e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO1—lung cancer	8.72e-06	6.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.71e-06	6.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.69e-06	6.52e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.61e-06	6.46e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—lung cancer	8.35e-06	6.27e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—lung cancer	8.34e-06	6.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	8.15e-06	6.12e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—lung cancer	8.13e-06	6.1e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUN—lung cancer	8.11e-06	6.09e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—STK11—lung cancer	8e-06	6e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—lung cancer	7.89e-06	5.92e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—lung cancer	7.87e-06	5.91e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—lung cancer	7.86e-06	5.9e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—lung cancer	7.85e-06	5.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—lung cancer	7.84e-06	5.89e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2E1—lung cancer	7.82e-06	5.87e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—lung cancer	7.8e-06	5.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NQO1—lung cancer	7.73e-06	5.8e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—lung cancer	7.66e-06	5.75e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—lung cancer	7.64e-06	5.73e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.51e-06	5.64e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EP300—lung cancer	7.48e-06	5.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—lung cancer	7.4e-06	5.55e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	7.37e-06	5.53e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—lung cancer	7.27e-06	5.46e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—lung cancer	7.26e-06	5.45e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAT—lung cancer	7.2e-06	5.41e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.16e-06	5.37e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—lung cancer	7.08e-06	5.32e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—lung cancer	7.01e-06	5.27e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—lung cancer	7e-06	5.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—lung cancer	7e-06	5.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STK11—lung cancer	6.97e-06	5.23e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—lung cancer	6.95e-06	5.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—lung cancer	6.88e-06	5.16e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—lung cancer	6.8e-06	5.11e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—lung cancer	6.8e-06	5.1e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—lung cancer	6.7e-06	5.03e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—lung cancer	6.52e-06	4.89e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—EP300—lung cancer	6.49e-06	4.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—lung cancer	6.45e-06	4.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A1—lung cancer	6.45e-06	4.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ERCC2—lung cancer	6.39e-06	4.8e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—lung cancer	6.38e-06	4.79e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAT—lung cancer	6.27e-06	4.71e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—lung cancer	6.25e-06	4.69e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—lung cancer	6.02e-06	4.52e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—lung cancer	5.99e-06	4.5e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—lung cancer	5.96e-06	4.47e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—lung cancer	5.92e-06	4.45e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—lung cancer	5.79e-06	4.35e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A1—lung cancer	5.62e-06	4.22e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ERCC2—lung cancer	5.57e-06	4.18e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—lung cancer	5.53e-06	4.15e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA1—lung cancer	5.53e-06	4.15e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—lung cancer	5.35e-06	4.02e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—lung cancer	5.3e-06	3.98e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.3e-06	3.98e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—lung cancer	5.12e-06	3.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—lung cancer	5.05e-06	3.79e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—lung cancer	4.9e-06	3.68e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA1—lung cancer	4.82e-06	3.62e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—POMC—lung cancer	4.81e-06	3.61e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—lung cancer	4.8e-06	3.6e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CREBBP—lung cancer	4.68e-06	3.51e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—lung cancer	4.52e-06	3.39e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—lung cancer	4.44e-06	3.33e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—lung cancer	4.4e-06	3.3e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—lung cancer	4.38e-06	3.29e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—POMC—lung cancer	4.19e-06	3.14e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CREBBP—lung cancer	4.08e-06	3.06e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—lung cancer	4.02e-06	3.02e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—lung cancer	3.92e-06	2.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—lung cancer	3.87e-06	2.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—lung cancer	3.87e-06	2.9e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—lung cancer	3.83e-06	2.88e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—lung cancer	3.82e-06	2.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—lung cancer	3.37e-06	2.53e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—lung cancer	3.34e-06	2.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—lung cancer	3.34e-06	2.51e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—EP300—lung cancer	3.19e-06	2.39e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—lung cancer	2.91e-06	2.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—EP300—lung cancer	2.78e-06	2.09e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—lung cancer	2.36e-06	1.77e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—lung cancer	2.05e-06	1.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—lung cancer	1.93e-06	1.45e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—lung cancer	1.68e-06	1.26e-05	CbGpPWpGaD
